Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2016 / Articles / Aug / Nominations for The Power List 2017
Manufacture Biosimilars Business Practice Clinical Trials Drug Delivery Ingredients Formulation Quality & Compliance Bioprocessing - Upstream & Downstream Technology and Equipment Analytical Science Advanced Medicine Trends & Forecasts Dosage Forms Technology & Manufacturing Business & Trends Development & Clinical Drug Delivery Formulation Regulation & Standards Bioprocessing Biopharma Cell & Gene

Nominations for The Power List 2017

By Stephanie Vine 08/19/2016 1 min read

Share

Who are the most influential and inspirational individuals in drug development and manufacturing? This is the driving question behind The Power List. The Medicine Maker’s annual Power List, published every April, compiles the top 100 most prominent and inspirational individuals involved in medicine making. Will the members of the 2016 list retain their places? Nominations for the 2017 list are now open and will close on February 1, 2017. Nominate now: http://tmm.txp.to/2017/powerlist

The Power List is a celebration of the entire field and process of medicine making, from small molecule to biologic and precision medicines. Anyone who has a part to play is eligible, including academics, technicians, regulators, consultants, vendors, philanthropists – it’s up to you to decide who is considered for the list. The full list of nominations will be passed to an independent panel and the top 100 will be published in the April 2017 issue of The Medicine Maker.

Nominate now: http://tmm.txp.to/2017/powerlist
Or email
: james.strachan@texerepublishing.com

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Stephanie Vine

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.

More Articles by Stephanie Vine

False

Advertisement

Recommended

False

Related Content

The Monoclonal Milestone
Biosimilars
The Monoclonal Milestone

December 1, 2014

0 min read

The launch of the world’s first biosimilar monoclonal antibody was a big step forward from a regulatory and scientific standpoint. Will there be enough room at the table?

Safety First - Sizing Up Biologics Side Effects
Standards & Regulation Biosimilars
Safety First - Sizing Up Biologics Side Effects

December 2, 2014

0 min read

Biologic medicines present unique challenges for pharmacovigilance. And with biosimilars hitting the market, life just got more complicated – especially when products share the same name.

Singular Head of Generics
Biosimilars
Singular Head of Generics

November 6, 2014

0 min read

Sitting Down With… Nick Haggar, Head of Western Europe, Middle East & Africa, Sandoz, and President of the European Generic Medicines Association (EGA).

Celebrating the Potential of Biosimilars
Supply Chain Biosimilars Bioprocessing - Upstream & Downstream
Celebrating the Potential of Biosimilars

February 5, 2025

3 min read

A look at how biosimilars can increase patient access to essential medicines, as well as improve performance in national and international healthcare systems.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.